3. Gheblawi M, Wang K, Viveiros A, et al. 2020; Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 126:1456–74. DOI:
10.1161/CIRCRESAHA.120.317015. PMID:
32264791. PMCID:
PMC7188049.
5. Zhang JJ, Dong X, Cao YY, et al. 2020; Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. [Epub ahead of print]. DOI:
10.1111/all.14238. PMID:
32077115.
Article
6. Qu R, Ling Y, Zhang YH, et al. 2020; Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. [Epub ahead of print]. DOI:
10.1002/jmv.25767. PMID:
32181903. PMCID:
PMC7228291.
Article
8. Xiong M, Liang X, Wei Y. 2020; Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Br J Haematol. [Epub ahead of print]. DOI:
10.1111/bjh.16725. PMID:
32304581. PMCID:
PMC7264726.
Article
9. Thachil J, Tang N, Gando S, et al. 2020; ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 18:1023–6. DOI:
10.1111/jth.14810. PMID:
32338827.
Article
10. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. 2020; Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress. 4:66–75. DOI:
10.15698/cst2020.04.216. PMID:
32292881.
Article
11. Dholaria B, Savani BN. 2020; How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat? Br J Haematol. 189:239–40. DOI:
10.1111/bjh.16597. PMID:
32180224. PMCID:
PMC7161755.
Article